Align Technology Inc Stock Price, News & Analysis

Align Technology (Nasdaq: ALGN) announced that President and CEO Joe Hogan has personally purchased approximately $1 million of Align's common stock. This purchase adds to his previous investments, totaling approximately $8 million in stock purchases since his last sale in 2021.

Hogan emphasized his confidence in Align's long-term value and commitment to increasing shareholder value through strategic investments in growth and next-generation technologies. Despite acknowledging ongoing macroeconomic uncertainties, the company maintains its focus on transforming treatment through its Invisalign® System, iTero™ scanners, and exocad™ software, serving over 286,400 doctor customers and targeting a 600 million consumer market opportunity worldwide.

Align Technology (NASDAQ:ALGN) reported mixed Q2 2025 financial results with total revenues of $1,012.4 million, up 3.4% sequentially but down 1.6% year-over-year. Clear Aligner revenues were $804.6 million, declining 3.3% year-over-year, while Imaging Systems revenues grew 5.6% to $207.8 million.

The company reported Q2 GAAP operating income of $163.0 million with a 16.1% margin, and non-GAAP operating margin of 21.3%. GAAP diluted EPS was $1.72, with non-GAAP EPS at $2.49.

Align announced a restructuring plan including workforce reductions and manufacturing optimization, expecting $150-170 million in one-time charges in H2 2025. The company aims to achieve GAAP operating margins of 13-14% and non-GAAP margins above 22.5% in FY 2025.

Align Technology (NASDAQ:ALGN) has announced the commercial launch of its innovative Invisalign System with mandibular advancement featuring occlusal blocks in Malaysia. This breakthrough technology is designed to treat Class II skeletal malocclusion in growing patients aged 10-16 while simultaneously straightening their teeth.

The new system represents a significant advancement in treating Class II malocclusions, which affect 30-45% of cases globally. The technology features integrated solid occlusal blocks with laser welding for improved durability and engagement, enabling earlier mandibular advancement in cases with deep bite. Key benefits include efficient treatment through a single process, enhanced patient comfort with SmartTrack material, and predictable tooth movement using SmartForce features and SmartStage technology.

Align Technology (NASDAQ:ALGN) has announced the commercial launch of its Invisalign Palatal Expander System in Malaysia, following its notification as a Class B medical device by the Malaysia Medical Device Authority. This innovative system, Align's first direct 3D printed orthodontic appliance, offers a metal-free alternative to traditional palatal expanders for skeletal and dental expansion.

The system consists of customized removable devices created using AI-driven orthodontic software and iTero intraoral digital scans. When combined with Invisalign First aligners, it provides a comprehensive early intervention treatment solution for growing patients. The technology is particularly significant for Phase 1 treatment, which represents 20% of orthodontic case starts annually and targets patients aged 6-10 years.

Align Technology (NASDAQ:ALGN) has announced the commercial launch of an innovative Invisalign System with mandibular advancement featuring occlusal blocks in Singapore. This breakthrough product is specifically designed for treating Class II skeletal and dental correction in growing patients aged 10-16 years.

The new system represents a significant advancement in orthodontic treatment, featuring integrated solid occlusal blocks that enable simultaneous mandibular advancement while aligning teeth. This innovation addresses Class II malocclusion, a common orthodontic problem affecting 30-45% of cases globally, where the lower jaw is positioned too far back relative to the upper jaw.

The product is currently available to Invisalign-trained doctors in Australia, New Zealand, Japan, Hong Kong, India, and Singapore, with planned expansion to additional APAC markets later in 2025.

Align Technology (NASDAQ:ALGN) has been announced as the title sponsor of Operation Smile's International Student Leadership Conference (ISLC) for the fifth consecutive year. The conference, in its 33rd year, will be held at the University of Maryland from July 21-27, 2025.

Align has committed over $1.6 million to student programs with Operation Smile, providing more than 130 scholarships since ISLC 2022. The scholarships cover travel costs and conference fees for students born with cleft conditions and those facing financial barriers across Operation Smile's network of 13,500 student volunteers from over 40 countries.

The partnership between Align Technology and Operation Smile spans more than a decade, supporting care for patients and working towards surgical excellence in 37 low- and middle-income countries.

Align Technology (NASDAQ: ALGN) has announced a strategic collaboration with Disney's upcoming movie sequel "Freakier Friday," set to release on August 8, 2025. The partnership features actress Julia Butters, a real-life Invisalign user, and includes product placement in the film alongside a comprehensive marketing campaign.

The multi-faceted collaboration encompasses co-branded content, social media campaigns, doctor's office activations, a Snapchat AR lens, and premiere events. The campaign aims to showcase how Invisalign clear aligners offer teens an effective and modern way to achieve confident smiles, while highlighting the system's near-invisibility and ease of use.

The marketing initiative leverages multiple channels including Disney+, Hulu, social media platforms, and orthodontist offices, reinforcing Align's commitment to teen confidence through smile transformation.

Align Technology (NASDAQ:ALGN) has announced the commercial availability of its innovative Invisalign System with mandibular advancement featuring occlusal blocks in India. This groundbreaking clear aligner product is specifically designed for Class II skeletal and dental correction in growing patients aged 10-16 years.

The system features integrated solid occlusal blocks that enable simultaneous mandibular advancement while aligning teeth, addressing approximately 30-45% of global malocclusions. Key benefits include efficient treatment through a single process, enhanced patient comfort with SmartTrack material, and predictable tooth movement using SmartForce features and SmartStage technology.

The product is currently available to Invisalign-trained doctors in Australia, New Zealand, Japan, Hong Kong, and India, with planned expansion to additional APAC markets later in 2025.

Align Technology (NASDAQ:ALGN) has announced the commercial launch of its Invisalign® Palatal Expander System in India following approval as a Class B medical device by the Central Drugs Standard Control Organization (CDSCO). This innovative system represents Align's first direct 3D printed orthodontic appliance.

The system offers a metal-free, removable alternative to traditional palatal expanders for treating skeletal and dental narrow maxilla. When combined with Invisalign First™ aligners, it provides doctors with a comprehensive early intervention treatment solution. The technology uses AI-driven orthodontic software and iTero™ intraoral digital scans to create customized devices that are changed daily, eliminating the need for manual screw adjustments.

This expansion into India follows successful launches in other Asia Pacific markets, including Australia, New Zealand, Hong Kong, Singapore, Vietnam, Japan, and Thailand, targeting the growing Phase 1 orthodontic treatment market, which represents 20% of orthodontic case starts annually.